Literature DB >> 441431

Effect of prostaglandins E1, E2 and F2alpha on neutrophil aggregation.

J T O'Flaherty, D L Kreutzer, P A Ward.   

Abstract

Recently we have found that chemotactic factors stimulate neutrophils in suspension to aggregate. Because of an obvious analogy to platelet aggregation, we examined the influence of three prostaglandins on this process. Prostaglandins E1, E2 and F2alpha alone did not cause aggregation of the neutrophils but were able to partially inhibit the aggregation response induced by the synthetic chemotactic tripeptide, formyl-methionyl-leucyl-phenylalanine. The minimal inhibitory concentrations for prostaglandins E1, E2 and F2alpha were 10(-7), 10(-6) and 10(-5)M, respectively. These results are similar to those found for the prostaglandin-induced inhibition of platelet aggregation. It may be, therefore, that neutrophil aggregation, like platelet aggregation, is modulated by intracellular prostaglandins and other products of arachidonic acid metabolism.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 441431     DOI: 10.1016/0090-6980(79)90039-x

Source DB:  PubMed          Journal:  Prostaglandins        ISSN: 0090-6980


  14 in total

1.  Proteolytic enzymes and arachidonic acid metabolites produced by MRC-5 cells on various microcarrier substrates.

Authors:  J Varani; J D Hasday; R G Sitrin; P G Brubaker; W A Hillegas
Journal:  In Vitro Cell Dev Biol       Date:  1986-10

2.  E-type prostaglandins but not iloprost inhibit platelet activating factor-induced generation of leukotriene B4 by human polymorphonuclear leukocytes.

Authors:  P Ney; K Schrör
Journal:  Br J Pharmacol       Date:  1989-01       Impact factor: 8.739

3.  Potentiation of neutrophil cyclooxygenase-2 by adenosine: an early anti-inflammatory signal.

Authors:  Jean-Sébastien Cadieux; Patrick Leclerc; Mireille St-Onge; Andrée-Anne Dussault; Cynthia Laflamme; Serge Picard; Catherine Ledent; Pierre Borgeat; Marc Pouliot
Journal:  J Cell Sci       Date:  2005-03-15       Impact factor: 5.285

4.  Immunomodulatory impact of the A2A adenosine receptor on the profile of chemokines produced by neutrophils.

Authors:  Shaun R McColl; Mireille St-Onge; Andrée-Anne Dussault; Cynthia Laflamme; Line Bouchard; Jean Boulanger; Marc Pouliot
Journal:  FASEB J       Date:  2005-11-09       Impact factor: 5.191

5.  Neutrophil-aggregating activity of monohydroxyeicosatetraenoic acids.

Authors:  J T O'Flaherty; M J Thomas; C J Lees; C E McCall
Journal:  Am J Pathol       Date:  1981-07       Impact factor: 4.307

6.  Aggregation of polymorphonuclear leucocytes (PMNs) by leukotriene B4: effects of cyclooxygenase products and metabolic inhibitors.

Authors:  F M Cunningham; H R Carter; M J Smith; A W Ford-Hutchinson; M A Bray
Journal:  Agents Actions       Date:  1981-12

7.  TVX 2706--a new phosphodiesterase inhibitor with antiinflammatory action. Biochemical characterization.

Authors:  T Glaser; J Traber
Journal:  Agents Actions       Date:  1984-10

8.  Equipotent inhibition by R(-)-, S(+)- and racemic ibuprofen of human polymorphonuclear cell function in vitro.

Authors:  M Villanueva; R Heckenberger; H Strobach; M Palmér; K Schrör
Journal:  Br J Clin Pharmacol       Date:  1993-03       Impact factor: 4.335

9.  Modulation of murine schistosomiasis by exogenously administered prostaglandins.

Authors:  S W Chensue; D G Remick; G I Higashi; D L Boros; S L Kunkel
Journal:  Am J Pathol       Date:  1986-10       Impact factor: 4.307

10.  Impact of anti-inflammatory agents on the gene expression profile of stimulated human neutrophils: unraveling endogenous resolution pathways.

Authors:  Mireille St-Onge; Aline Dumas; Annick Michaud; Cynthia Laflamme; Andrée-Anne Dussault; Marc Pouliot
Journal:  PLoS One       Date:  2009-03-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.